Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dead money. Has been and continues to get closer to ZERO. No signs of anything changing anything some. Maybe the company should use Kevetrin to keep from dying from cancer.
Where is the OM deal? Mgmt seems to be the only people making money here.
surprised there is anyone still following this company. They have failed to deliver a good deal. The last deal was ridiculous for shareholders. Mgmt will continue to get their inflated wages for awhile and then it will end.
Why is anyone investigating in IPIX? They have failed to deliver for years.
bottom line the company hasnt been able to get funding for OM trial. Market is tired of hearing the inability to get funding. The rest is just noise.
the stock price pretty much sums it up the sentiment of the company at this point.
still no deal for Brilacidin OM after getting FDA approval to continue on. We should of had a deal by now. Very little interest is the logical response.
the show has been over for months. Just waiting to slowly go to zero now.
ZS along with many other cyber stocks is the area to be right now. Could retest $80 level in a few weeks from $72. Last earnings were good.
18 months and still no funding, partnership or trials set for phase 3. Dont expect anything to come from the medical convention going on. If they have a deal on the table they would of told us by now.
Still have no specifics on when Brilacidin will be used to start the next trial. No indication when the sachets will actually be available for trial or how the progress has been going on its development. No indication on where we will get funding to continue. Just a lot of speculation. Its been over a year since the Brilacidin phase 3 trials ended. I see no sense of urgency just a lot of talk. The share price tells how the market feels about its potential.
We still have no funding to pay for the sachet or when it will be available. No funding no phase 3 trial. Too much uncertainty at this point. The stock remains at current levels until funding comes about.
The Kevetrin results are statistically irrelevant. Investors are only interested in the future of Brilacidin. No funds then the stock goes to ZERO.
Stop with the RS. It is not happening. Not an important issue. We need funding to continue operations. Bottom line. The rest is just noise.
They havent shown that they can get any funding to continue to a phase 3 with Brilacidin. There is speculation on funding but that is it.
A lawsuit wont fix anything. They dont have the funding to protect the company.
IPIX isnt being attacked they just arent delivering. Prurisol trial didnt work out, funding is getting scarce, Kevetrin potentail is just that and is there much of a market for Brilacidin. Without funding for another trial we might never know. The only things we do know is the large salaries that are due each month and that a company is working on a sachet form for the drug that has no time frame for availability or when a trial might even begin. Partnership no one really knows. That stock will continue to go lower. That isnt being negative that is just the way things are now.
The price has been reflecting that the market has very little faith in the company and its ability to continue going forward.
Top issues.
1) CRO payment for Prurisol must occur. The drug testing goes nowhere without it unless the companies feels the results arent good enough. Prurisol might be worth billions some day but right now its ZERO with potential.
2) How much longer before we proceed with Brilacidin. Do we even have enough funds to go on to next trial phase?
3) We only have limited funds but how much of that will be paid for salaries and not trials.
4) Kevetrin has potential but there is no funding to move it to the next phase. Dont expect much to happen for a couple of years.
5) Dont expect a partnership to occur. Will have to go it alone. Most likely Leo doesnt like the terms.
Things just keep getting pushed and funding is getting less and less.
Wow an on topic msg. Prurisol trials completed last year with no results to date. Brilacidin - we have a company working on another means of dispersing the drug with no time frame or how much it will cost. Kevetrin has pretty much been put on hold. We have a conference coming up that IPIX will present. The outlook is cloudy at best. There is no evidence of a partnership or how we can get enough funding to pay for additional trials. Money has been raised but it wont last long. It becomes very easy on why the share price reflects the market sentiment.
We still have ZERO results or FDA meetings for Prurisol.
After more than 10 months we have no evidence of a FDA meeting to proceed with the development of the drugs
wont be any worse than it is now. Something is not right here. The trial results for Prurisol should of occurred by now.
If you believe in the Science you should be buying very heavily here. The buyout will eventually occur at a min of $20/sh. Otherwise find another stock. This is a once in a lifetime opportunity.
Almost out of money, no results from Prurisol trial, no money to pay for companies to work on making an oral drug, no CDRs or evidence of them, etc. We are very close to the end for shareholders. PRs at this point are just a lot of fluff and have little impact on future trials or staying afloat.
Absolutely nothing wrong with today news release.
The same people continue to post BS rhetoric month after month. They have to be compensated for their nonsense. No reasonable person has the time to write the same BS every day. If you have an issue contact the company or move on.
No reverse in the works. That is the least of our concerns at this point.
this is what we know
1) company continues to dilute the stock
2) needs to raise money because cash is short (another $7m from Aspire with no understanding how and where the money will be spent)
3) Mgmt continues to draw high salaries
4) corerx to formulate and package brilacidin but at what cost and time frame. We have no funds to start the next trial phase particularly since the last trial ended in 4Q 2017
5) Prurisol trial results is still in limbo
6) Kevetrin on hold no funding
7) any patents are slowing eroding away time wise
There has been no evidence of any partnership just a lot of speculation. Investors are showing no confidence and is reflected in the share price. Whether Prurisol can produce is yet to be seen.
Right now I dont see anything happening on the next trial phase until next year 2019.
Either we are doing more stock dilution or things arent looking good with the results.
This is currently little confidence in the company. Only speculation of what might be. They raised more cash but that should last to the end of the year. No money to continue with the next trials or pay for Brilacidin further development. If there is no change in the companies situation soon they will probably go under.
P has not shown failure. Where is your evidence? Just alot of whining rhetoric. When the results are known whether good or bad, we will all know.
Typical BS rhetoric as usual from the same people every day. Everything depends on Prurisol results. Everything else is noise.
Bankruptcy not likely. Yesterday volume told us that the volume was higher than normal nothing more or less. More BS rhetoric with no evidence just more of the same. Your messages are about as useful as Georges.
Who is they that is selling? More specific than rhetoric. Somebody is buying those shares who expect the stock to go higher, but we dont talk about that.
Speculation about why he did it has not been shown in your posts but only the assumption that it was done for a unknown reason that you have no evidence to support. Just more rhetoric. The science is all that matters whether its good or bad. Try contacting the company to get your answers. Nobody on this board has them.
This information is irrelevant to the current status of the company. The only thing that matters is the science. This isnt a Mueller investigation into info that has no bearing on the current trials. It is very tiresome reading garbage that most of this board keeps pushing. If the science doesnt work the company goes under. Its the only thing that matters.
What exactly was the misleading statement on his education? What was the misleading information on drug development? What was the misleading information on uplisting, BOD, ABSSSI P3 and SPA, Timeline for Kevetrin, Prurisol development etc. Been following the company for years. You need to provide detailed info or get removed from the board for BS rhetoric.
Please list all the misleading statements. You make a blanket statement now its time to provide them for the board. You should be able to do that right?
What? Market Cap too high, based on what. We have three potential drugs and no revenue. If you have been with other small drug companies the share price is totally arbitrary. So based on your nonsense what is a good price. $.01, $.10, $.20, $.40, $1.00 etc. When the partnership is announced they will still have no revenue. So what will the price be? So stop with the nonsense.